Nuveen
PTHS icon

Nuveen’s Pelthos Therapeutics PTHS Stock Holding History

Nuveen’s Portfolio PTHS Stock Details PTHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.82K Buy
+326
New +$8.3K ﹤0.01% 4613

Other funds holding PTHS

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Nuveen's PTHS Position: Q3 2026 in Review

Nuveen opened a new position in Pelthos Therapeutics (PTHS) in Q3 2026: 326 shares worth $6.82K. The stake represents ﹤0.01% of the portfolio and ranks #4613 among its holdings.

6 funds tracked by Wall St. Rank hold PTHS as of Q3 2026.

  • Nuveen held 326 shares of Pelthos Therapeutics worth $6.82K as of Q3 2026.
  • Pelthos Therapeutics was a new Nuveen position in Q3 2026.
  • Pelthos Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4613 holding.
  • 6 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.